Literature DB >> 17216203

Renalase gene is a novel susceptibility gene for essential hypertension: a two-stage association study in northern Han Chinese population.

Qi Zhao1, Zhongjie Fan, Jiang He, Shufeng Chen, Hongfan Li, Penghua Zhang, Laiyuan Wang, Dongsheng Hu, Jianfeng Huang, Boqin Qiang, Dongfeng Gu.   

Abstract

Renalase, a novel flavin adenine dinucleotide-dependent amine oxidase, is secreted by the kidney, degrades circulating catecholamines, and modulates cardiac function and systemic blood pressure (BP). Its discovery may provide novel insights into the mechanisms of BP regulation and the pathogenesis of essential hypertension (EH). We designed a two-stage case-control study to investigate whether the renalase gene harbored any genetic variants associated with EH in the northern Han Chinese population. From the International Collaborative Study of Cardiovascular Disease in Asia (InterASIA in China), 1,317 hypertensive cases and 1,269 normotensive controls were recruited. These total 2,586 subjects were taken as the main study population in this study. In stage 1, all the eight selected single nucleotide polymorphisms (SNPs) of the renalase gene were genotyped and tested within a subsample (503 cases and 490 controls) of the main study population. By single locus analyses, three SNPs, rs2576178, rs2296545, and rs2114406, showed significant associations with EH (P < 0.05). In stage 2, these three SNPs were genotyped on the remaining individuals and analyzed using all the individuals. After Bonferroni correction for multiple comparisons, the associations of rs2576178 and rs2296545 with EH were still significant in stage 2. The cases had higher frequencies of rs2576178 G allele and rs2296545 C allele than the controls (0.55 versus 0.49, P < 0.0001; 0.61 versus 0.55, P < 0.0001). Particularly, under the codominant model, the adjusted odds ratios for rs2576178 GG genotype and rs2296545 CC genotype were 1.58 (95% CI, 1.25 to 2.00; P = 0.0002) and 1.61 (95% CI, 1.26 to 2.04; P = 0.0002), respectively. We also found risk-associated haplotypes and diplotypes, which further confirmed the significant association between the renalase gene and EH. These findings may provide novel genetic susceptibility markers for EH and lead to a better understanding of EH pathophysiology. In addition, further replications in other populations and functional studies would be warranted.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17216203     DOI: 10.1007/s00109-006-0151-4

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  24 in total

Review 1.  Role of dopamine receptors in the kidney in the regulation of blood pressure.

Authors:  Pedro A Jose; Gilbert M Eisner; Robin A Felder
Journal:  Curr Opin Nephrol Hypertens       Date:  2002-01       Impact factor: 2.894

2.  Prevalence, awareness, treatment, and control of hypertension in china.

Authors:  Dongfeng Gu; Kristi Reynolds; Xigui Wu; Jing Chen; Xiufang Duan; Paul Muntner; Guanyong Huang; Robert F Reynolds; Shaoyong Su; Paul K Whelton; Jiang He
Journal:  Hypertension       Date:  2002-12       Impact factor: 10.190

Review 3.  [Genetics and essential hypertension: candidate genes or screening of the whole genome?].

Authors:  A P Gimenez-Roqueplo; X Jeunemaitre
Journal:  Arch Mal Coeur Vaiss       Date:  2003-11

4.  Estimation and tests of haplotype-environment interaction when linkage phase is ambiguous.

Authors:  S L Lake; H Lyon; K Tantisira; E K Silverman; S T Weiss; N M Laird; D J Schaid
Journal:  Hum Hered       Date:  2003       Impact factor: 0.444

5.  What makes a good genetic association study?

Authors:  Andrew T Hattersley; Mark I McCarthy
Journal:  Lancet       Date:  2005-10-08       Impact factor: 79.321

6.  Association study with 33 single-nucleotide polymorphisms in 11 candidate genes for hypertension in Chinese.

Authors:  Dongfeng Gu; Shaoyong Su; Dongliang Ge; Shufeng Chen; Jianfeng Huang; Biao Li; Runsheng Chen; Boqin Qiang
Journal:  Hypertension       Date:  2006-04-24       Impact factor: 10.190

7.  Prevalence of the metabolic syndrome and overweight among adults in China.

Authors:  Dongfeng Gu; Kristi Reynolds; Xigui Wu; Jing Chen; Xiufang Duan; Robert F Reynolds; Paul K Whelton; Jiang He
Journal:  Lancet       Date:  2005 Apr 16-22       Impact factor: 79.321

8.  Renalase, a catecholamine-metabolizing hormone from the kidney.

Authors:  Friedrich C Luft
Journal:  Cell Metab       Date:  2005-06       Impact factor: 27.287

Review 9.  Renal dopamine receptors in health and hypertension.

Authors:  P A Jose; G M Eisner; R A Felder
Journal:  Pharmacol Ther       Date:  1998-11       Impact factor: 12.310

10.  Two-stage designs for gene-disease association studies with sample size constraints.

Authors:  Jaya M Satagopan; E S Venkatraman; Colin B Begg
Journal:  Biometrics       Date:  2004-09       Impact factor: 2.571

View more
  44 in total

Review 1.  Novel therapeutic targets for hypertension.

Authors:  Ludovit Paulis; Thomas Unger
Journal:  Nat Rev Cardiol       Date:  2010-06-22       Impact factor: 32.419

Review 2.  Novel insights into the physiology of renalase and its role in hypertension and heart disease.

Authors:  Gary Desir
Journal:  Pediatr Nephrol       Date:  2011-03-20       Impact factor: 3.714

3.  Genome-wide association studies suggest that APOL1-environment interactions more likely trigger kidney disease in African Americans with nondiabetic nephropathy than strong APOL1-second gene interactions.

Authors:  Carl D Langefeld; Mary E Comeau; Maggie C Y Ng; Meijian Guan; Latchezar Dimitrov; Poorva Mudgal; Mitzie H Spainhour; Bruce A Julian; Jeffrey C Edberg; Jennifer A Croker; Jasmin Divers; Pamela J Hicks; Donald W Bowden; Gary C Chan; Lijun Ma; Nicholette D Palmer; Robert P Kimberly; Barry I Freedman
Journal:  Kidney Int       Date:  2018-06-07       Impact factor: 10.612

4.  Dynamic genetic linkage of intermediate blood pressure phenotypes during postural adaptations in a founder population.

Authors:  I A Arenas; J Tremblay; B Deslauriers; J Sandoval; O Šeda; D Gaudet; E Merlo; T Kotchen; A W Cowley; P Hamet
Journal:  Physiol Genomics       Date:  2012-12-26       Impact factor: 3.107

5.  Relationship between Renalase Expression and Kidney Disease: an Observational Study in 72 Patients Undergoing Renal Biopsy.

Authors:  Yi-Sha Huang; Jian-Bo Lai; Sheng-Fa Li; Ting Wang; Ying-Nan Liu; Qing-Xia Zhang; Shu-Yuan Zhang; Chun-Han Sun; Nan Hu; Xin-Zhou Zhang
Journal:  Curr Med Sci       Date:  2018-04-30

Review 6.  Phosducin - a candidate gene for stress-dependent hypertension.

Authors:  Guido Grassi
Journal:  J Clin Invest       Date:  2009-12       Impact factor: 14.808

Review 7.  Renalase and Biomarkers of Contrast-Induced Acute Kidney Injury.

Authors:  Maciej T Wybraniec; Katarzyna Mizia-Stec
Journal:  Cardiorenal Med       Date:  2015-09-19       Impact factor: 2.041

8.  A functional polymorphism in renalase (Glu37Asp) is associated with cardiac hypertrophy, dysfunction, and ischemia: data from the heart and soul study.

Authors:  Ramin Farzaneh-Far; Gary V Desir; Beeya Na; Nelson B Schiller; Mary A Whooley
Journal:  PLoS One       Date:  2010-10-20       Impact factor: 3.240

Review 9.  Renalase: its role as a cytokine, and an update on its association with type 1 diabetes and ischemic stroke.

Authors:  Xiaojia Guo; Ling Wang; Heino Velazquez; Robert Safirstein; Gary V Desir
Journal:  Curr Opin Nephrol Hypertens       Date:  2014-09       Impact factor: 2.894

10.  Emilin1 gene and essential hypertension: a two-stage association study in northern Han Chinese population.

Authors:  Chong Shen; Xiangfeng Lu; Yun Li; Qi Zhao; Xiaoli Liu; Liping Hou; Laiyuan Wang; Shufeng Chen; Jianfeng Huang; Dongfeng Gu
Journal:  BMC Med Genet       Date:  2009-11-18       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.